Structure of an IgNAR-AMA1 complex: targeting a conserved hydrophobic cleft broadens malarial strain recognition - Wikidata - wikimedia - TriplyDB

Structure of an IgNAR-AMA1 complex: targeting a conserved hydrophobic cleft broadens malarial strain recognition

Structure of an IgNAR-AMA1 complex: targeting a conserved hydrophobic cleft broadens malarial strain recognition

http://www.wikidata.org/entity/Q27649017

about

Structural Characterization of Apical Membrane Antigen 1 (AMA1) from Toxoplasma gondii Host cell invasion by apicomplexan parasites: insights from the co-structure of AMA1 with a RON2 peptide Babesia divergensandNeospora caninumapical membrane antigen 1 structures reveal selectivity and plasticity in apicomplexan parasite host cell invasion PAN-modular structure of microneme protein SML-2 from the parasite Sarcocystis muris at 1.95 Å resolution and its complex with 1-thio-β-D-galactose Atypical Antigen Recognition Mode of a Shark Immunoglobulin New Antigen Receptor (IgNAR) Variable Domain Characterized by Humanization and Structural Analysis Structural and Functional Insights into the Malaria Parasite Moving Junction Complex Single domain antibodies: promising experimental and therapeutic tools in infection and immunity HIV-1 fusion is blocked through binding of GB Virus C E2-derived peptides to the HIV-1 gp41 disulfide loop [corrected]Molecular insights into the interaction between Plasmodium falciparum apical membrane antigen 1 and an invasion-inhibitory peptide The RON2-AMA1 interaction is a critical step in moving junction-dependent invasion by apicomplexan parasites Multilevel Precision-Based Rational Design of Chemical Inhibitors Targeting the Hydrophobic Cleft of Toxoplasma gondii Apical Membrane Antigen 1 (AMA1)An inhibitory antibody blocks interactions between components of the malarial invasion machinery.Llama single domain antibodies specific for the 7 botulinum neurotoxin serotypes as heptaplex immunoreagents.VNAR single-domain antibodies specific for BAFF inhibit B cell development by molecular mimicry Peptide inhibitors of the malaria surface protein, apical membrane antigen 1: identification of key binding residues High affinity antibodies to Plasmodium falciparum merozoite antigens are associated with protection from malaria.Human peripheral blood antibodies with long HCDR3s are established primarily at original recombination using a limited subset of germline genes.CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells.Cheminformatics Based Machine Learning Models for AMA1-RON2 Abrogators for Inhibiting Plasmodium falciparum Erythrocyte Invasion.Use of immunodampening to overcome diversity in the malarial vaccine candidate apical membrane antigen 1.Anti-tumor necrosis factor VNAR single domains reduce lethality and regulate underlying inflammatory response in a murine model of endotoxic shock Immunodiagnosis of neurocysticercosis: ways to focus on the challenge Computational and biophysical approaches to protein-protein interaction inhibition of Plasmodium falciparum AMA1/RON2 complex.Crystal structure of Plasmodium knowlesi apical membrane antigen 1 and its complex with an invasion-inhibitory monoclonal antibody.Changes Related to Age in Natural and Acquired Systemic Self-IgG Responses in Malaria.Stability of the Plasmodium falciparum AMA1-RON2 Complex Is Governed by the Domain II (DII) Loop Engineered Autonomous Human Variable Domains Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma.Glypican-3 antibodies: a new therapeutic target for liver cancer.Surface plasmon resonance for vaccine design and efficacy studies: recent applications and future trends.Biotechnological applications of recombinant single-domain antibody fragments.Immunoglobulin domains in Escherichia coli and other enterobacteria: from pathogenesis to applications in antibody technologies.Screening for small molecule inhibitors of Toxoplasma gondii.Structural insights and biomedical potential of IgNAR scaffolds from sharks.The apicomplexan glideosome and adhesins - Structures and function.Single-domain antibodies for biomedical applications.Recombinant λ bacteriophage displaying nanobody towards third domain of HER-2 epitope inhibits proliferation of breast carcinoma SKBR-3 cell line.Cross-reactivity between apical membrane antgen 1 and rhoptry neck protein 2 in P. vivax and P. falciparum: A structural and binding study Single-Domain Antibodies As Versatile Affinity Reagents for Analytical and Diagnostic Applications.Allosteric inhibition of Aurora-A kinase by a synthetic vNAR domain.

P2860

Q27660294-7731D221-DAE5-4D32-98CD-7BC5E5AA2816 Q27670931-D622B99A-9AB6-464E-8872-F2D7EBE3676C Q27675189-EBE04000-987A-4F6E-8B30-09420680CDF2 Q27675667-CBBE0986-B334-4F6B-B70B-B1B4C8E0F171 Q27677883-44D04A72-BB9B-492F-B732-6140A85113BC Q27681409-474F900D-13CA-4631-A721-6270A9C2D5BA Q28248678-6861692B-B618-4283-ABA6-5E194BBB87FA Q28485218-A120FCB1-7865-414A-BCDC-C171471BA4BE Q28544106-4BF10C0E-B523-4D0F-98A1-C333CA2DD511 Q28742887-7A9BAD52-2A92-4450-808F-D91610AF8BC0 Q28829567-F3FEF001-3D97-416E-8CDA-3DBEAE1904A3 Q33402457-617E1355-76A5-4A35-91A2-65FB54A1ADFC Q33526251-4E719251-984A-4613-8C1A-292253F60F30 Q33688370-0BDD2488-5F83-4D42-9D1A-04D812FF4E19 Q33788027-E0088136-E2AB-41A0-BE63-93100AAF324F Q34171724-1FEE29AA-33FE-4712-8288-DA75B1596F71 Q34270980-BF625FE8-D601-42EE-B4C1-6BBC9AAB629D Q34377450-0447492E-6EA7-4B02-B029-7E45E2A6EC17 Q34536422-E63F3B51-D6E2-4AA3-8BB6-B9340FF54BE9 Q34596157-0ED4D331-C2EF-442A-BD0C-14C3F23CAFB2 Q34645352-ECED530B-81AA-44D8-BD3D-8A25061C5E0C Q35498241-6A03CC3F-2492-446E-AA09-E385EB88E025 Q35589799-A9BAA6E9-D20E-4940-A25E-6C81A50A0FC2 Q35606847-13500259-A28D-4F30-AC95-E8EEC621A173 Q35664136-91A45287-73D2-44A5-85C3-A71F162B9286 Q35885751-3FD2927F-FFBE-431A-85D6-4E887E35A4D2 Q36140177-DA53A3CB-827F-4D54-AE19-A069B359E816 Q36712597-DDCEBCB5-632D-46F3-BAF0-BE4E54E009C7 Q37625736-B3056EAD-2A47-45F6-BC48-71492C9BA043 Q37762275-983FC531-538C-4F32-BD7F-6E8AD0C313FB Q37887077-F4CEF800-0A37-4BE5-98BB-2893D4205340 Q38020872-620D4675-4D1D-45D5-B89C-479C1ACCE4B8 Q38045464-5DA49B25-19D1-48D4-9F6B-F4BCA4EC45C6 Q38293902-C232CEBD-51F3-4F17-A486-E4E96B6CD016 Q38375594-2351F7D0-3E0B-4EC7-8271-10958F07795B Q38628712-F57D3458-A1E8-403B-BBF6-2AEFDB19F746 Q39229818-D82B1A84-C2B2-4FA6-A7BC-78914D290165 Q39566107-495FAF91-636D-475B-925C-9B489AB00DB8 Q41484905-9684773D-248C-470A-BF2B-771F628ED60C Q41868025-65AA0434-9021-4169-AF59-3F6A9520A8D6

P2860

Structure of an IgNAR-AMA1 complex: targeting a conserved hydrophobic cleft broadens malarial strain recognition

http://www.wikidata.org/entity/Q27649017

description

2007 nî lūn-bûn

@nan

2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Structure of an IgNAR-AMA1 com ...... ns malarial strain recognition

@ast

Structure of an IgNAR-AMA1 com ...... ns malarial strain recognition

@en

Structure of an IgNAR-AMA1 com ...... ns malarial strain recognition

@nl

type

label

Structure of an IgNAR-AMA1 com ...... ns malarial strain recognition

@ast

Structure of an IgNAR-AMA1 com ...... ns malarial strain recognition

@en

Structure of an IgNAR-AMA1 com ...... ns malarial strain recognition

@nl

prefLabel

Structure of an IgNAR-AMA1 com ...... ns malarial strain recognition

@ast

Structure of an IgNAR-AMA1 com ...... ns malarial strain recognition

@en

Structure of an IgNAR-AMA1 com ...... ns malarial strain recognition

@nl

P1433

Q27649017-30EF4AB6-713B-49C4-84D9-97DFB5112926

P1476

Q27649017-8F448590-3505-461D-AE2D-628FDBAECB86

P2093

Q27649017-0BDE9AA7-FA19-4197-BB49-FDF627B41F36

Q27649017-19E2A9B5-94FA-4FA9-B2D3-DC0454465FD8

Q27649017-2CF81F87-A31F-43D8-8B1E-AE16183E9E6A

Q27649017-4157CD44-F6F6-4DA8-8F51-6C6174D78705

Q27649017-5DF73EE0-A233-451E-8FBB-AB314BEBDD65

Q27649017-6F84908F-82FA-4BB4-B401-622C1A7076D6

Q27649017-7E5FE251-1ECE-401C-8F5D-AFE37BF2E94E

Q27649017-8A6CE2A7-5528-4ECE-B4CE-A8B2D97E128A

Q27649017-9ACD34C8-13CF-4056-B415-2408480E48AE

Q27649017-A3D4404C-ED6A-4F47-AB88-A55CC32F1FCC

P304

Q27649017-CF410DBB-FD1D-4386-80C2-D85A916DD8B9

P31

Q27649017-D0D3154A-BB39-46A8-AF04-29AC10D451DC

P3181

Q27649017-43F4C229-F8B9-4775-A77B-093EECE07323

P356

Q27649017-E082EC02-BD42-4B82-96E0-7FA6902189BB

P433

Q27649017-8CC58AE1-2545-462E-827A-7ECB36E10297

P478

Q27649017-FADC160E-7E04-47DB-88FF-6CAC03573651

P50

Q27649017-2283A334-79A3-4C77-ABC5-3401337DD780

P577

Q27649017-0FCDAA97-5A8C-4739-90D6-D18C96BBB43B

P5875

Q27649017-DFC1EB24-3CA2-407E-8F19-AEDFDCD8FF91

P698

Q27649017-FA266822-C657-46C6-9058-88444CA0BA54

P921

Q27649017-01117E5C-CFB9-460D-B984-6A67CAB54475

Q27649017-2E430C17-F198-484C-8A2F-E64061E4D42D

P3181

P356

J.STR.2007.09.011

P1433

P1476

Structure of an IgNAR-AMA1 com ...... ns malarial strain recognition

@en

P2093

Aditi Gupta

http://www.w3.org/2001/XMLSchema#string

Adrian H Batchelor

http://www.w3.org/2001/XMLSchema#string

Andrew M Coley

http://www.w3.org/2001/XMLSchema#string

Kylie A Henderson

http://www.w3.org/2001/XMLSchema#string

Michael Foley

http://www.w3.org/2001/XMLSchema#string

Olan Dolezal

http://www.w3.org/2001/XMLSchema#string

Peter J Hudson

http://www.w3.org/2001/XMLSchema#string

Stewart D Nuttall

http://www.w3.org/2001/XMLSchema#string

Tao Bai

http://www.w3.org/2001/XMLSchema#string

Victor A Streltsov

http://www.w3.org/2001/XMLSchema#string

P304

1452-66

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

379259

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.STR.2007.09.011

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Robin Fredric Anders

P577

2007-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5848866

http://www.w3.org/2001/XMLSchema#string

P698

17997971

http://www.w3.org/2001/XMLSchema#string

P921